Atlas Trials

Phase I/II Study of hLL1 in Multiple Myeloma

Clinical trial NCT00421525 · COMPLETED

Trial details

NCT number
NCT00421525
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple MyelomaMyeloma, Plasma-CellPLASMACYTOMA
Start date
2007-01-01
Primary completion
2009-06-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.